<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医麦客 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-19T12:20:06+08:00</updated>
  <subtitle>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>治疗结直肠癌，全球首个非基因编辑的同种异体CAR-T临床项目公布1期临床结果丨医麦猛爆料</title>
    <updated>2021-01-19T11:50:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/zpIxyG0iiiFNegxA5Nxi_Q</id>
    <link href="https://mp.weixin.qq.com/s/zpIxyG0iiiFNegxA5Nxi_Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内首例！博雅辑因CRISPR/Cas9基因编辑疗法获批临床丨医麦猛爆料</title>
    <updated>2021-01-19T11:50:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/RcGfobkRWWyq-ejHO5HnlQ</id>
    <link href="https://mp.weixin.qq.com/s/RcGfobkRWWyq-ejHO5HnlQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CD30 CAR-T进入后期临床开发阶段，聊一聊Tessa公司多种CAR疗法的开发方向丨医麦猛爆料</title>
    <updated>2021-01-19T11:50:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/3bE1WSXmAW5YIg2s74azeQ</id>
    <link href="https://mp.weixin.qq.com/s/3bE1WSXmAW5YIg2s74azeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>赛默飞9亿美元加码病毒载体制造，强化细胞与基因治疗产能丨医麦新观察</title>
    <updated>2021-01-19T11:50:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/QVk5A1YWNaNCxStIzW1d2A</id>
    <link href="https://mp.weixin.qq.com/s/QVk5A1YWNaNCxStIzW1d2A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药融资丨免疫刺激抗体偶联平台拟募资1亿美元IPO</title>
    <updated>2021-01-19T11:50:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/nt9P3lZX68FrS0OYuK4IBA</id>
    <link href="https://mp.weixin.qq.com/s/nt9P3lZX68FrS0OYuK4IBA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>博腾生物副总经理隋礼丽：自带CDMO基因，一体化CDMO服务赋能行业丨峰客创见</title>
    <updated>2021-01-17T23:14:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/K9W5K9CMrnlyIFxnxrK3Xw</id>
    <link href="https://mp.weixin.qq.com/s/K9W5K9CMrnlyIFxnxrK3Xw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature子刊：2020年生物制药交易分析丨医麦新观察</title>
    <updated>2021-01-17T23:14:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/LHs0Xti58GlLKs1BzIVdEg</id>
    <link href="https://mp.weixin.qq.com/s/LHs0Xti58GlLKs1BzIVdEg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药融资丨原能医学A轮融资超过2亿元 加速产品临床研究和注册申报</title>
    <updated>2021-01-17T23:14:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/g-N6ZvnIlH_AEQASiVCHHg</id>
    <link href="https://mp.weixin.qq.com/s/g-N6ZvnIlH_AEQASiVCHHg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药融资丨超20亿大手笔投资，富士胶片2021年伊始扩大细胞与基因治疗领域产能</title>
    <updated>2021-01-17T23:14:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/XokqTFXk4BZUlN_KCmsRwA</id>
    <link href="https://mp.weixin.qq.com/s/XokqTFXk4BZUlN_KCmsRwA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>时隔不到一年D轮再获1.35亿美元投资！帮助Kite和诺华可以精准预测CAR-T治疗有效性的居然是它丨医麦猛爆料</title>
    <updated>2021-01-16T23:08:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/kjh-J81NtIMyq15H85ucnw</id>
    <link href="https://mp.weixin.qq.com/s/kjh-J81NtIMyq15H85ucnw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>iPSC研究资助加速，临床潜能进一步释放 | 医麦新观察</title>
    <updated>2021-01-16T23:08:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/AbqFgnlZcawp6v9AjafnQQ</id>
    <link href="https://mp.weixin.qq.com/s/AbqFgnlZcawp6v9AjafnQQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药融资丨下一个Juno？继7亿美元首轮融资后，细胞治疗公司Sana计划筹集1.5亿美元的IPO</title>
    <updated>2021-01-16T23:08:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/uTFF3vvOz96YC8DrAoMMYQ</id>
    <link href="https://mp.weixin.qq.com/s/uTFF3vvOz96YC8DrAoMMYQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亘喜生物苏州生产基地获得CAR-T细胞治疗产品《药品生产许可证》丨医麦猛爆料</title>
    <updated>2021-01-15T18:41:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/CmyDLGBwFNT53fa2VvyVSw</id>
    <link href="https://mp.weixin.qq.com/s/CmyDLGBwFNT53fa2VvyVSw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>干货丨J.P. Morgan 2021三天全收集，未来发展与投资风向</title>
    <updated>2021-01-15T18:41:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/iHHbWoZww_GPMZW0tnLK4A</id>
    <link href="https://mp.weixin.qq.com/s/iHHbWoZww_GPMZW0tnLK4A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Science子刊：用于产前诊断出的遗传性疾病，脂质纳米颗粒递送mRNA显示出强大潜力丨医麦黑科技</title>
    <updated>2021-01-15T18:41:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/RMsImgiuYc2j4VAT_ECj1Q</id>
    <link href="https://mp.weixin.qq.com/s/RMsImgiuYc2j4VAT_ECj1Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠病毒致肿瘤消退，对溶瘤病毒免疫治疗领域的启示丨峰客论见</title>
    <updated>2021-01-15T18:41:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/0q8lGmEV1-hCYKG5wh6v4g</id>
    <link href="https://mp.weixin.qq.com/s/0q8lGmEV1-hCYKG5wh6v4g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>强生公布其新冠疫苗I/IIa期临床中期数据，单剂量疫苗至少产生71天的免疫应答丨医麦猛爆料</title>
    <updated>2021-01-15T18:41:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/8iT-j18m3EcJUYaa81ZJkg</id>
    <link href="https://mp.weixin.qq.com/s/8iT-j18m3EcJUYaa81ZJkg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅 |《治疗用生物制品病毒污染风险控制要点》正式发布</title>
    <updated>2021-01-14T19:10:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/UqWO3iQpL4VRgKEccQxZ5Q</id>
    <link href="https://mp.weixin.qq.com/s/UqWO3iQpL4VRgKEccQxZ5Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>LILRB2单抗治疗实体瘤进入1期临床，巨噬细胞靶向疗法热度不减丨医麦猛爆料</title>
    <updated>2021-01-14T19:10:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/FrU1kwzqDy3pCPf1AsXgpg</id>
    <link href="https://mp.weixin.qq.com/s/FrU1kwzqDy3pCPf1AsXgpg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>复宏汉霖逾1亿美元布局TROP-2单抗丨医麦猛爆料</title>
    <updated>2021-01-14T19:10:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/MkqLzuZFCskLisG4v9Mhtg</id>
    <link href="https://mp.weixin.qq.com/s/MkqLzuZFCskLisG4v9Mhtg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>